BioTrinity Conference 2021
Partner, James Tumbridge is speaking at this year’s BioTrinity conference, taking place from the 21 – 25 June 2021, in the format of a new live interactive hybrid event. James will be speaking on the first day of the conference (Monday 21 June, 12.30 – 13:00) presenting, ‘Brexit: An update for life sciences’.
James will also be joined by Senior Associate, Emma Longland who will be attending the event and available for networking opportunities and to answer any IP related questions on the day.
BioTrinity is a highly regarded biopartnering & investment life sciences conference, that aims to shine a light on new innovation in the life sciences industry and inspire growth and create opportunities for all who attend.
The 2021 event will be delivered in a true hybrid format, and will provide seamless live interaction for delegates, who include early-stage and emerging biotech, medtech and digital health companies, big pharma executives, life sciences investors and service providers.
